Investigate Policy Horizons Canada, International Electrotechnical Commission, National Nanotechnology Initiative, Israel Innovation Authority, Standards Council of Canada...
It is interesting that a lot of this 'oneness' / hivemind stuff is like a lot of these plans are captured and streamlined in both the 'select narrative' and the counter narrative camps, so that both are heading for the same result. This win-win situation permeates everything they do.
Good to know James is one of the few who recognize that CV-19 is a fabrication without denying the existence of viruses altogether. Viruses are actually being used as a tool for IoBNT, genetic engineering, drug delivery, etc. Those denying the existence of all viruses keep people uninformed about these realities. For example, in the parvovirus family, there is a virus called the adeno-associated virus capable of passing through the blood-brain barrier. Optogenetic gene therapy, programming brain neurons to be sensitive to specific wavelengths of light, can be accomplished using AAV viral vectors injected intravenously. (1) This means a brain-computer interface can be established using a "vaccine", and with the development of LiFi and optoelectronic technology, this is particularly relevant. The possibilities for genetic programming are virtually endless. For example, I recently discovered articles discussing how AAV viral vectors can be used to either increase or decrease the production of amyloid beta proteins in the brain (2). Ideally, it would be used to prevent the onset of brain disorders by decreasing production, but we should be concerned that there may be an agenda to increase the production of amyloid beta proteins. It has been discovered to be present in many who have taken the jab (3). It should be noted that amyloid beta proteins have fluorescent properties and can self-assemble into optoelectronic technology within the body and brain (4). This means that the natural proteins inside our body can be deliberately caused to misfold (turned into junk) and the materials can then be repurposed into what is essentially computer chips capable of emitting the light frequencies necessary to control our reprogrammed cells/neurons. All of this can be accomplished using "vaccines".
(1) No Implants Needed For Precise Control Deep Into The Brain
(2) Intra- and extracellular β-amyloid overexpression via adeno-associated virus-mediated gene transfer impairs memory and synaptic plasticity in the hippocampus
Thanks for sharing this.
It is interesting that a lot of this 'oneness' / hivemind stuff is like a lot of these plans are captured and streamlined in both the 'select narrative' and the counter narrative camps, so that both are heading for the same result. This win-win situation permeates everything they do.
Good to know James is one of the few who recognize that CV-19 is a fabrication without denying the existence of viruses altogether. Viruses are actually being used as a tool for IoBNT, genetic engineering, drug delivery, etc. Those denying the existence of all viruses keep people uninformed about these realities. For example, in the parvovirus family, there is a virus called the adeno-associated virus capable of passing through the blood-brain barrier. Optogenetic gene therapy, programming brain neurons to be sensitive to specific wavelengths of light, can be accomplished using AAV viral vectors injected intravenously. (1) This means a brain-computer interface can be established using a "vaccine", and with the development of LiFi and optoelectronic technology, this is particularly relevant. The possibilities for genetic programming are virtually endless. For example, I recently discovered articles discussing how AAV viral vectors can be used to either increase or decrease the production of amyloid beta proteins in the brain (2). Ideally, it would be used to prevent the onset of brain disorders by decreasing production, but we should be concerned that there may be an agenda to increase the production of amyloid beta proteins. It has been discovered to be present in many who have taken the jab (3). It should be noted that amyloid beta proteins have fluorescent properties and can self-assemble into optoelectronic technology within the body and brain (4). This means that the natural proteins inside our body can be deliberately caused to misfold (turned into junk) and the materials can then be repurposed into what is essentially computer chips capable of emitting the light frequencies necessary to control our reprogrammed cells/neurons. All of this can be accomplished using "vaccines".
(1) No Implants Needed For Precise Control Deep Into The Brain
https://spectrum.ieee.org/deep-brain-control-without-implants
(1) Delivering Genes Across the Blood-Brain Barrier
https://www.caltech.edu/about/news/delivering-genes-across-blood-brain-barrier-49679
(1) Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
https://www.nature.com/articles/nbt.3440
https://www.nature.com/articles/nbt.3440.epdf?shared_access_token=NsuDvkysVdAD-NMobf92MtRgN0jAjWel9jnR3ZoTv0Oc1C4EC6mihtCoEiOiojmlbm3jFLWwcszi01fOEGBkcVl_2jFS1NjJokA3vSfALBFaLCMFDHMSBEH74tmMDFlIYVLEQiNhHu_AKA0N-NAKfH_F9YqnFs5zCh9xyt_u_9U%3D
(2) Intra- and extracellular β-amyloid overexpression via adeno-associated virus-mediated gene transfer impairs memory and synaptic plasticity in the hippocampus
https://www.nature.com/articles/s41598-019-52324-0
(2) https://scholar.google.com/scholar?q=aav+amyloid+beta
(3) Amyloid β-related angiitis of the central nervous system occurring after COVID-19 vaccination: A case report
https://www.wjgnet.com/2307-8960/full/v10/i34/12617.htm
(3) A case of cerebral amyloid angiopathy related inflammation after vaccination against SARS-CoV-2
https://www.sciencedirect.com/science/article/pii/S2667257X22000663
(4) Self-assembling peptide semiconductors
https://www.science.org/doi/10.1126/science.aam9756
(4) Conformable self-assembling amyloid protein coatings with genetically programmable functionality
https://www.science.org/doi/full/10.1126/sciadv.aba1425
(4) Fluorescence Phenomena in Amyloid and Amyloidogenic Bionanostructures
https://www.mdpi.com/2073-4352/10/8/668